Drug repurposing for glioblastoma based on molecular subtypes
Authors:
- 1 December 2016
- journal article
- Published by Elsevier in Journal of Biomedical Informatics
- Vol. 64, 131-138
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Towards building a disease-phenotype knowledge base: extracting disease-manifestation relationship from literatureBioinformatics, 2013
- Genome-wide Generation and Systematic Phenotyping of Knockout Mice Reveals New Roles for Many GenesCell, 2013
- Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposingBMC Bioinformatics, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- PhenomeNET: a whole-phenome approach to disease gene discoveryNucleic Acids Research, 2011
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- PREDICT: a method for inferring novel drug indications with application to personalized medicineMolecular Systems Biology, 2011
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- The Human Phenotype Ontology: A Tool for Annotating and Analyzing Human Hereditary DiseaseThe American Journal of Human Genetics, 2008